Holloway Caroline L, Macklin Eric A, Cormack Robert A, Viswanathan Akila N
Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Brachytherapy. 2011 Jul-Aug;10(4):313-7. doi: 10.1016/j.brachy.2010.10.005. Epub 2010 Dec 30.
To assess the dose to the organs at risk (OARs) and utility of repeated OAR dose-volume histogram calculations in multifraction high-dose-rate vaginal cylinder brachytherapy using 3-dimensional imaging.
Thirty-eight patients (125 fractions) received high-dose-rate brachytherapy to the vaginal vault between January 2005 and October 2005. All patients emptied their bladders before insertion. After each insertion, a CT scan with 2.5-mm slices and contours of the bladder, rectum, and sigmoid was performed. Dose-volume histograms were generated for the D(0.1cc) and D(2cc) for the OAR using a software program created at our institution. Variance component models estimated the within-patient variance of the dose to the OAR between fractions. Predictors of dose to the OAR were identified using linear mixed models.
The within-patient coefficients of variation of total D(0.1cc) dose were bladder 14.0%, rectum 7.9%, and sigmoid 27.6%; for D(2cc), these were 8.1%, 5.9%, and 20.3%, respectively. Intraclass correlations ranged from 0.27 to 0.79. Larger OAR predicted greater total D(0.1cc) and D(2cc). Other predictors of total D(0.1cc) and D(2cc) dose included the size of the cylinder and the length of the treatment field for rectum.
CT simulation provides a noninvasive assessment of the dose to the bladder, rectum, and sigmoid. The small within-patient variation in doses to the bladder and rectum do not support reporting doses to the OARs beyond the initial fraction.
使用三维成像评估多分割高剂量率阴道柱状近距离放射治疗中危及器官(OARs)的剂量以及重复进行OAR剂量体积直方图计算的效用。
2005年1月至2005年10月期间,38例患者(125个分割)接受了阴道穹窿的高剂量率近距离放射治疗。所有患者在插入前排空膀胱。每次插入后,进行层厚为2.5毫米的CT扫描,并勾勒出膀胱、直肠和乙状结肠的轮廓。使用我们机构创建的软件程序生成OAR的D(0.1cc)和D(2cc)的剂量体积直方图。方差成分模型估计了分割间OAR剂量的患者内方差。使用线性混合模型确定OAR剂量的预测因素。
患者内总D(0.1cc)剂量的变异系数分别为:膀胱14.0%,直肠7.9%,乙状结肠27.6%;对于D(2cc),这些系数分别为8.1%、5.9%和20.3%。组内相关性范围为0.27至0.79。较大的OAR预测总D(0.1cc)和D(2cc)更高。总D(0.1cc)和D(2cc)剂量的其他预测因素包括柱状体大小和直肠治疗野长度。
CT模拟提供了对膀胱、直肠和乙状结肠剂量的无创评估。膀胱和直肠剂量的患者内小变异不支持在初始分割之外报告OARs的剂量。